Utestående aktier | 6,993,406 shares |
Insideraktier | 5 401 084 shares |
Insynsägande | 77,23 % |
Totalt antal insynspersoner | 32 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5030 out of 11219Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Minerva Neurosciences, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
Frederick W Ahlholm SVP, CFO and Secretary - [O] | 17 518 | 17 518 | |
Plc Barclays
10% Owner -
|
196 800 | 196 800 | |
Boehringer Ingelheim International Gmbh
10% Owner -
|
2 550 000 | 2 550 000 | |
Marc D Beer Director - [D] | 50 000 | 6 250 | |
Care Capital III LLC
10% Owner -
|
1 662 592 | 207 824 | |
Care Capital Investments III L.P.
10% Owner -
|
1 662 592 | 207 824 | |
Care Capital Offshore Investments III LP
10% Owner -
|
1 662 592 | 207 824 | |
William F Doyle Director - [D] | 26 111 | 3 264 | |
Michael Davidson Chief Medical Officer - [O] | 0 | 0 | |
Rubertis Francesco De
Director, 10% Owner -
[D]
|
4 690 906 | 586 363 |
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
Hans Peter Hasler Director - [D] | 10 000 | 1 250 | |
Jeryl L Hilleman Director - [D] | 1 000 | 125 | |
Venture Associates III Ltd Index
10% Owner -
|
3 899 189 | 487 399 | |
Venture Associates IV Ltd Index
10% Owner -
|
3 899 189 | 487 399 | |
Venture Associates V Ltd Index
10% Owner -
|
3 899 189 | 487 399 | |
& Johnson Johnson
10% Owner -
|
0 | 0 | |
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
0 | 0 | |
David Kupfer Director - [D] | 163 553 | 20 444 | |
Fouzia Laghrissi-Thode Director - [D] | 0 | 0 | |
Levine Mark S. SVP,General Counsel & Sec. - [O] | 0 | 0 | |
Remy Luthringer CEO, Director - [D] [O] | 184 819 | 184 819 |
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
Michele Ollier
Director, 10% Owner -
[D]
|
4 690 906 | 586 363 | |
Lorenzo Pellegrini
Director, 10% Owner -
[D]
|
3 883 212 | 485 402 | |
Geoff Race President - [O] | 51 324 | 51 324 | |
Reilly Joseph H. SVP & Chief Operating Officer - [O] | 31 747 | 3 968 | |
Russell Richard E. President - [O] | 33 770 | 4 221 | |
Jay Saoud | 100 000 | ||
Devin Whittemore Smith | 85 000 | ||
Heek G Jan Van Director - [D] | 20 333 | 2 542 | |
Nico Vandervelpen Director - [D] | 0 | 0 | |
Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] | 41 667 | 5 208 | |
(Jersey) SLP Yucca
10% Owner -
|
3 899 189 | 487 399 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NERV / Minerva Neurosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i NERV / Minerva Neurosciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-07-07 | 3 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | NERV | Common Stock | D | 1 275 000 | ||||||||
2023-05-02 | 2023-05-02 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,7600 | −3 641 | −14 | 68 994 | ||||
2023-05-02 | 2023-05-01 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,8500 | −23 753 | −91 | 72 635 | ||||
2023-05-02 | 2023-04-28 | 4 | Luthringer Remy | NERV | Common Stock | D | 88 077 | 96 388 | ||||||
2023-05-02 | 2023-05-01 | 4 | Race Geoff | NERV | Common Stock | D | 3,8500 | −22 082 | −85 | 51 324 | ||||
2023-05-02 | 2023-04-28 | 4 | Race Geoff | NERV | Common Stock | D | 46 987 | 73 406 | ||||||
2023-05-02 | 2023-05-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,4800 | −3 580 | −16 | 17 518 | ||||
2023-05-02 | 2023-04-28 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 19 843 | 21 098 | ||||||
2022-08-10 | 3 | BARCLAYS PLC By Barclays Capital Inc. | NERV | Common Stock, $0.0001 par value per share | I | 196 800 | ||||||||
2022-08-10 | 3 | BARCLAYS PLC By Barclays Bank PLC | NERV | Common Stock, $0.0001 par value per share | I | 408 430 | ||||||||
2022-02-18 | 2022-02-16 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 0,79 | 180 000 | 180 000 | |||||
2022-02-18 | 2022-02-16 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 0,79 | 505 000 | 505 000 | |||||
2022-02-18 | 2022-02-16 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 0,79 | 200 000 | 200 000 | |||||
2021-12-03 | 2021-12-01 | 4 | Kupfer David | NERV | Common Stock | D | 0,8800 | −55 635 | −49 | 163 553 | ||||
2021-06-16 | 2021-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 2,90 | 20 000 | 20 000 | |||||
2021-06-15 | 2021-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 2,90 | 40 000 | 40 000 | |||||
2021-06-15 | 2021-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 2,90 | 20 000 | 20 000 | |||||
2021-06-15 | 2021-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 2,90 | 20 000 | 20 000 | |||||
2021-06-15 | 2021-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 2,90 | 20 000 | 20 000 | |||||
2021-06-15 | 2021-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 2,90 | 20 000 | 20 000 | |||||
2020-12-16 | 2020-12-16 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 2,6400 | −3 228 | −9 | 31 747 | ||||
2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | −8 750 | 0 | ||||||
2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8 750 | 34 975 | ||||||
2020-12-16 | 2020-12-16 | 4 | Race Geoff | NERV | Common Stock | D | 2,6400 | −6 190 | −16 | 211 354 | ||||
2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | −12 500 | 0 | ||||||
2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12 500 | 217 544 | ||||||
2020-12-16 | 2020-12-16 | 4 | Luthringer Remy | NERV | Common Stock | D | 2,6400 | −1 300 | −3 | 66 490 | ||||
2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | −18 750 | 0 | ||||||
2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18 750 | 67 790 | ||||||
2020-12-16 | 2020-12-16 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 2,6400 | −1 845 | −5 | 10 039 | ||||
2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | −5 000 | 0 | ||||||
2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5 000 | 11 884 | ||||||
2020-10-14 | 2020-10-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 3,50 | 200 000 | 200 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 3,50 | 140 000 | 140 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85 000 | 85 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85 000 | 85 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 3,50 | 100 000 | 100 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85 000 | 85 000 | |||||
2020-10-14 | 2020-10-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85 000 | 85 000 | |||||
2020-09-11 | 2020-09-10 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 2,9700 | 7 000 | 21 | 20 333 | ||||
2020-08-17 | 2020-06-19 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153 531 | 153 531 | |||||
2020-08-17 | 2020-06-19 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 275 568 | 275 568 | |||||
2020-08-17 | 2020-06-19 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137 784 | 137 784 | |||||
2020-08-17 | 2020-06-19 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 354 302 | 354 302 | |||||
2020-08-17 | 2020-06-19 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153 531 | 153 531 | |||||
2020-08-17 | 2020-06-19 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 185 025 | 185 025 | |||||
2020-08-17 | 2020-06-19 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 236 202 | 236 202 | |||||
2020-08-17 | 2020-06-19 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137 784 | 137 784 | |||||
2020-06-12 | 2020-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 3,40 | 40 000 | 40 000 | |||||
2020-06-12 | 2020-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 3,40 | 20 000 | 20 000 | |||||
2020-06-12 | 2020-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 3,40 | 20 000 | 20 000 | |||||
2020-06-12 | 2020-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 3,40 | 20 000 | 20 000 | |||||
2020-06-12 | 2020-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 3,40 | 20 000 | 20 000 | |||||
2020-06-12 | 2020-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 3,40 | 20 000 | 20 000 | |||||
2020-05-27 | 2020-05-26 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 15,0000 | −8 339 | −125 | 6 884 | ||||
2020-01-03 | 2019-12-31 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 74 432 | 74 432 | |||||
2020-01-03 | 2019-12-31 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41 469 | 41 469 | |||||
2020-01-03 | 2019-12-31 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 49 975 | 49 975 | |||||
2020-01-03 | 2019-12-31 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 63 798 | 63 798 | |||||
2020-01-03 | 2019-12-31 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41 469 | 41 469 | |||||
2020-01-03 | 2019-12-31 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37 216 | 37 216 | |||||
2020-01-03 | 2019-12-31 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37 216 | 37 216 | |||||
2020-01-03 | 2019-12-31 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 95 698 | 95 698 | |||||
2019-12-17 | 2019-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,1000 | −5 826 | −41 | 205 044 | ||||
2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | −12 500 | 12 500 | ||||||
2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12 500 | 210 870 | ||||||
2019-12-17 | 2019-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,1000 | −2 724 | −19 | 26 225 | ||||
2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | −8 750 | 8 750 | ||||||
2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8 750 | 28 949 | ||||||
2019-12-17 | 2019-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,1000 | −1 557 | −11 | 15 223 | ||||
2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | −5 000 | 5 000 | ||||||
2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5 000 | 16 780 | ||||||
2019-12-17 | 2019-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,1000 | −2 412 | −17 | 49 040 | ||||
2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | −18 750 | 18 750 | ||||||
2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18 750 | 51 452 | ||||||
2019-12-13 | 2019-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,4200 | −3 113 | −23 | 33 770 | ||||
2019-07-01 | 2019-06-27 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 5,5000 | 3 500 | 19 | 26 111 | ||||
2019-06-27 | 2019-06-26 | 4 | Kupfer David | NERV | Common Stock | D | 5,5500 | 10 000 | 56 | 219 188 | ||||
2019-06-27 | 2019-06-26 | 4 | HASLER HANS PETER | NERV | Common Stock | D | 5,6000 | 10 000 | 56 | 10 000 | ||||
2019-06-27 | 2019-06-26 | 4 | HILLEMAN JERYL L | NERV | Common Stock | D | 5,2500 | 1 000 | 5 | 1 000 | ||||
2019-06-27 | 2019-06-26 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 5,3700 | 10 000 | 54 | 13 333 | ||||
2019-06-26 | 2019-06-24 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0144 | −197 000 | −1 185 | 3 899 189 | ||||
2019-06-21 | 2019-06-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,3413 | −33 575 | −146 | 4 096 189 | ||||
2019-06-21 | 2019-06-19 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4425 | −77 243 | −343 | 4 129 764 | ||||
2019-06-19 | 2019-06-18 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4393 | −49 675 | −221 | 4 207 007 | ||||
2019-06-19 | 2019-06-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4487 | −56 243 | −250 | 4 256 682 | ||||
2019-06-17 | 2019-06-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4971 | −25 169 | −113 | 4 312 925 | ||||
2019-06-17 | 2019-06-13 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5133 | −53 298 | −241 | 4 338 094 | ||||
2019-06-13 | 2019-06-12 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5719 | −26 901 | −123 | 4 391 392 | ||||
2019-06-13 | 2019-06-11 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,7769 | −33 150 | −158 | 4 418 293 | ||||
2019-06-13 | 2019-06-12 | 4 | DOYLE WILLIAM F | NERV | Stock option (right to buy) | D | 4,50 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-31 | 2019-05-31 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 5,21 | 20 000 | 20 000 | |||||
2019-05-21 | 2019-05-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0750 | −200 | −1 | 4 451 443 | ||||
2019-05-21 | 2019-05-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0164 | −22 718 | −137 | 4 451 643 | ||||
2019-05-16 | 2019-05-16 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,3715 | −44 836 | −286 | 4 474 361 | ||||
2019-05-16 | 2019-05-15 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,6357 | −53 418 | −354 | 4 519 197 | ||||
2019-05-16 | 2019-05-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 7,0548 | −36 574 | −258 | 4 572 615 | ||||
2018-12-26 | 2018-12-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 6,5000 | 2 000 | 13 | 22 611 | ||||
2018-12-18 | 2018-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,4600 | −2 728 | −20 | 20 199 | ||||
2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | −8 750 | 17 500 | ||||||
2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8 750 | 22 927 | ||||||
2018-12-18 | 2018-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,4600 | −2 604 | −19 | 32 702 | ||||
2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | −18 750 | 37 500 | ||||||
2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18 750 | 35 306 | ||||||
2018-12-18 | 2018-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,4600 | −1 559 | −12 | 11 780 | ||||
2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | −5 000 | 10 000 | ||||||
2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5 000 | 13 339 | ||||||
2018-12-18 | 2018-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,4600 | −5 999 | −45 | 198 370 | ||||
2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | −12 500 | 25 000 | ||||||
2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12 500 | 204 369 | ||||||
2018-12-13 | 2018-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,9600 | −3 117 | −25 | 36 883 | ||||
2018-12-13 | 2018-12-11 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 260 000 | 260 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,96 | 96 000 | 96 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120 000 | 120 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120 000 | 120 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175 000 | 175 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,96 | 410 000 | 410 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175 000 | 175 000 | |||||
2018-12-13 | 2018-12-11 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120 000 | 120 000 | |||||
2018-12-12 | 2018-12-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 7,9500 | 4 000 | 32 | 20 611 | ||||
2018-12-12 | 2018-12-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,0000 | 2 000 | 16 | 16 611 | ||||
2018-11-21 | 2018-11-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,2000 | 2 000 | 16 | 14 611 | ||||
2018-10-15 | 2018-10-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,0000 | 600 | 6 | 12 611 | ||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | −10 000 | 47 524 | |||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | −15 000 | 27 400 | |||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,6200 | −1 700 | −21 | 14 177 | ||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0200 | −23 300 | −280 | 15 877 | ||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,1900 | 10 000 | 52 | 39 177 | ||||
2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 15 000 | 71 | 29 177 | ||||
2018-10-03 | 2018-10-01 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,3509 | −15 444 | −191 | 4 609 189 | ||||
2018-10-01 | 2018-09-28 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,6151 | −34 589 | −436 | 4 624 633 | ||||
2018-10-01 | 2018-09-27 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,5702 | −31 684 | −398 | 4 659 222 | ||||
2018-09-19 | 2018-09-17 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 1 800 | 19 | 12 011 | ||||
2018-09-17 | 2018-09-14 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 200 | 2 | 10 211 | ||||
2018-09-17 | 2018-09-13 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 2 000 | 21 | 10 011 | ||||
2018-09-11 | 2018-09-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,7200 | 4 011 | 39 | 8 011 | ||||
2018-09-11 | 2018-09-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,8800 | 4 000 | 40 | 4 000 | ||||
2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | −25 000 | 42 400 | |||||
2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 10,0000 | −25 000 | −250 | 14 177 | ||||
2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 25 000 | 118 | 39 177 | ||||
2018-08-02 | 2018-08-01 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (Righ to Buy) | D | 7,95 | 200 000 | 200 000 | |||||
2018-08-02 | 2018-08-01 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 7,95 | 20 000 | 20 000 | |||||
2018-07-17 | 2018-07-16 | 4 | HILLEMAN JERYL L | NERV | Stock Option (Right to Buy) | D | 8,20 | 40 000 | 40 000 | |||||
2018-06-11 | 2018-06-07 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 8,25 | 20 000 | 20 000 | |||||
2018-06-11 | 2018-06-07 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 8,25 | 20 000 | 20 000 | |||||
2018-06-11 | 2018-06-07 | 4 | HASLER HANS PETER | NERV | Stock Option (Right to Buy) | D | 8,25 | 20 000 | 20 000 | |||||
2018-06-11 | 2018-06-07 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 8,25 | 20 000 | 20 000 | |||||
2018-06-11 | 2018-06-07 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 8,25 | 20 000 | 20 000 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | 12 500 | 12 500 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | −12 500 | 0 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | −12 500 | 0 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | 7 500 | 7 500 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | −7 500 | 0 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127 513 | 127 513 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | −127 513 | 0 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | 80 356 | 80 356 | |||||
2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | −80 356 | 0 | |||||
2018-01-04 | 2018-01-02 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,20 | 200 000 | 200 000 | |||||
2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | −12 500 | 37 500 | ||||||
2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 5,7900 | −5 829 | −34 | 191 869 | ||||
2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12 500 | 197 698 | ||||||
2017-12-15 | 2017-12-13 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 200 000 | 200 000 | |||||
2017-12-15 | 2017-12-13 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 175 000 | 175 000 | |||||
2017-12-15 | 2017-12-13 | 4 | Davidson Michael | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 125 000 | 125 000 | |||||
2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | −5 000 | 15 000 | ||||||
2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,8000 | −1 661 | −10 | 8 339 | ||||
2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5 000 | 10 000 | ||||||
2017-12-15 | 2017-12-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120 000 | 120 000 | |||||
2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | −8 750 | 26 250 | ||||||
2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,8000 | −2 906 | −17 | 14 177 | ||||
2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8 750 | 17 083 | ||||||
2017-12-15 | 2017-12-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120 000 | 120 000 | |||||
2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | −18 750 | 56 250 | ||||||
2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 5,8500 | −2 194 | −13 | 16 556 | ||||
2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18 750 | 18 750 | ||||||
2017-12-15 | 2017-12-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 350 000 | 350 000 | |||||
2017-12-12 | 2017-12-10 | 4 | DOYLE WILLIAM F | NERV | Option Grant (Right to Buy) | D | 5,70 | 40 000 | 40 000 | |||||
2017-12-12 | 2017-12-10 | 4 | HASLER HANS PETER | NERV | Option Grant (Right to Buy) | D | 5,70 | 40 000 | 40 000 | |||||
2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Employee Stock option (Right to Buy) | D | 6,05 | 775 000 | 775 000 | |||||
2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Common Stock | D | 40 000 | 40 000 | ||||||
2017-09-14 | 2017-08-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 0,0001 | −3 892 256 | −0 | 0 | ||||
2017-09-05 | 2017-09-01 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,45 | 100 000 | 100 000 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | 12 500 | 12 500 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | −12 500 | 0 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | −12 500 | 0 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | 25 000 | 25 000 | |||||
2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | −25 000 | 0 | |||||
2017-06-05 | 2017-06-01 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-06-05 | 2017-06-01 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | −7 250 | 49 750 | |||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | −14 381 | 43 143 | |||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 11,0000 | −10 381 | −114 | 5 000 | ||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 10,0000 | −11 250 | −112 | 15 381 | ||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 7 250 | 34 | 26 631 | ||||
2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,1900 | 14 381 | 75 | 19 381 | ||||
2017-06-05 | 2017-06-01 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-06-05 | 2017-06-01 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | −17 500 | 39 774 | |||||
2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 11,0000 | −17 500 | −192 | 0 | ||||
2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 17 500 | 91 | 17 500 | ||||
2017-06-05 | 2017-06-01 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12 500 | 12 500 | |||||
2017-03-21 | 2017-03-20 | 4 | Beer Marc D | NERV | Common Stock | D | 7,8900 | 25 000 | 197 | 50 000 | ||||
2017-03-21 | 2017-03-17 | 4 | Beer Marc D | NERV | Common Stock | D | 8,3400 | 25 000 | 208 | 25 000 | ||||
2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | −2 185 | 285 719 | |||||
2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0000 | −2 185 | −24 | 0 | ||||
2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 2 185 | 10 | 2 185 | ||||
2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | −32 096 | 287 904 | |||||
2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0200 | −32 096 | −354 | 0 | ||||
2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 32 096 | 151 | 32 096 | ||||
2017-02-07 | 2017-02-06 | 4 | Race Geoff | NERV | Common Stock | D | 11,0000 | −1 692 | −19 | 185 198 | ||||
2017-02-07 | 2017-02-03 | 4 | Race Geoff | NERV | Common Stock | D | 11,0200 | −19 758 | −218 | 186 890 | ||||
2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Stock Option (Right to Buy) | D | 4,71 | −1 600 | 67 400 | |||||
2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0300 | −1 600 | −19 | 8 333 | ||||
2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 1 600 | 8 | 9 933 | ||||
2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 5,19 | −250 | 57 274 | |||||
2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 4,71 | −17 250 | 51 750 | |||||
2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 12,0000 | −17 500 | −210 | 0 | ||||
2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 250 | 1 | 17 500 | ||||
2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 4,7100 | 17 250 | 81 | 17 250 | ||||
2017-01-05 | 2017-01-03 | 4 | Davidson Michael | NERV | Stock Option (Right to Buy) | D | 11,75 | 145 000 | 145 000 | |||||
2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | −12 000 | 57 000 | |||||
2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 12,5100 | −17 000 | −213 | 5 000 | ||||
2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 12 000 | 57 | 22 000 | ||||
2016-12-20 | 3 | Davidson Michael | NERV | Common Stock | D | 0 | ||||||||
2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35 000 | 35 000 | |||||
2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | 20 000 | 20 000 | ||||||
2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 100 000 | 100 000 | |||||
2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | 50 000 | 50 000 | ||||||
2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 13,45 | 150 000 | 150 000 | |||||
2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | 75 000 | 75 000 | ||||||
2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 60 000 | 60 000 | |||||
2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | 35 000 | 35 000 | ||||||
2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35 000 | 35 000 | |||||
2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Restricted Stock Units | D | 20 000 | 20 000 | ||||||
2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | −202 634 | 0 | |||||
2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 5,7720 | 202 634 | 1 170 | 4 690 906 | ||||
2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | −202 634 | 0 | |||||
2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 5,7720 | 202 634 | 1 170 | 4 690 906 | ||||
2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | −202 634 | 0 | |||||
2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 5,7720 | 202 634 | 1 170 | 4 690 906 | ||||
2016-08-12 | 2016-08-10 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 10,0000 | −1 000 000 | −10 000 | 4 488 272 | ||||
2016-08-12 | 2016-08-10 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 10,0000 | −1 000 000 | −10 000 | 4 488 272 | ||||
2016-08-12 | 2016-08-10 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 10,0000 | −1 000 000 | −10 000 | 4 488 272 | ||||
2016-06-21 | 2016-06-21 | 4 | Kupfer David By wife | NERV | Common Stock | I | 10,7250 | 27 935 | 300 | 27 935 | ||||
2016-06-21 | 2016-06-20 | 4 | Kupfer David | NERV | Common Stock | D | 10,9530 | 27 700 | 303 | 209 188 | ||||
2016-06-17 | 2016-06-16 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 10,20 | 12 500 | 12 500 | |||||
2016-06-17 | 2016-06-16 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 10,20 | 12 500 | 12 500 | |||||
2016-06-17 | 2016-06-16 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 10,20 | 12 500 | 12 500 | |||||
2016-06-17 | 2016-06-16 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 10,20 | 12 500 | 12 500 | |||||
2016-06-17 | 2016-06-16 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 10,20 | 12 500 | 12 500 | |||||
2016-03-18 | 2016-03-17 | 4 | Kupfer David | NERV | Common Stock | D | 5,5100 | 181 488 | 1 000 | 181 488 | ||||
2016-02-12 | 2015-03-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,9300 | 607 903 | 2 997 | 3 892 256 | ||||
2015-12-08 | 2015-12-04 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 4,71 | 69 000 | 69 000 | |||||
2015-12-08 | 2015-12-04 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 4,71 | 69 000 | 69 000 | |||||
2015-12-08 | 2015-12-04 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 4,71 | 175 000 | 175 000 | |||||
2015-12-08 | 2015-12-04 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 4,71 | 320 000 | 320 000 | |||||
2015-12-08 | 2015-12-04 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 4,71 | 69 000 | 69 000 | |||||
2015-12-08 | 2015-12-04 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 4,71 | 25 000 | 25 000 | |||||
2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
2015-11-03 | 2015-11-02 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,41 | 25 000 | 25 000 | |||||
2015-06-18 | 2015-06-17 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 25 000 | 25 000 | ||||||
2015-05-18 | 3 | Laghrissi-Thode Fouzia | NERV | Common Stock | D | 0 | ||||||||
2015-04-16 | 2015-02-02 | 4/A | Beer Marc D | NERV | Stock Option (right to buy) | D | 7 500 | 7 500 | ||||||
2015-04-16 | 2015-04-14 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 5,19 | 57 524 | 57 524 | |||||
2015-04-16 | 2015-04-14 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 5,19 | 213 133 | 213 133 | |||||
2015-04-16 | 2015-04-14 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 5,19 | 399 623 | 399 623 | |||||
2015-04-16 | 2015-04-14 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 5,19 | 57 524 | 57 524 | |||||
2015-04-16 | 2015-04-14 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 5,19 | 57 524 | 57 524 | |||||
2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202 634 | 25 | 202 634 | |||
2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 4,8100 | 202 634 | 975 | 5 488 272 | ||||
2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 6,2500 | −6 700 | −42 | 1 662 592 | ||||
2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,7500 | −1 200 000 | −6 900 | 1 669 292 | ||||
2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202 634 | 25 | 202 634 | |||
2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 4,8100 | 202 634 | 975 | 5 488 272 | ||||
2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202 634 | 25 | 202 634 | |||
2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 4,8100 | 202 634 | 975 | 5 488 272 | ||||
2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. | NERV | Warrants (right to buy) | I | 5,77 | 0,1250 | 607 903 | 76 | 607 903 | |||
2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,8100 | 607 903 | 2 924 | 4 500 159 | ||||
2015-02-04 | 2015-02-02 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 7 500 | 7 500 | ||||||
2015-02-04 | 2015-02-02 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 7 500 | 7 500 | ||||||
2015-01-26 | 2015-01-26 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,0200 | −23 111 | −116 | 2 869 292 | ||||
2015-01-26 | 2015-01-23 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1400 | −63 304 | −325 | 2 892 403 | ||||
2015-01-26 | 2015-01-22 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1100 | −395 697 | −2 022 | 2 955 707 | ||||
2015-01-08 | 2015-01-08 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,6600 | −70 659 | −400 | 3 351 404 | ||||
2015-01-08 | 2015-01-07 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,8500 | −64 278 | −376 | 3 422 063 | ||||
2015-01-08 | 2015-01-06 | 4 | Care Capital III LLC | NERV | Common Stock | I | 7,9400 | −396 871 | −3 151 | 3 486 341 | ||||
2014-09-03 | 2014-09-02 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 7,10 | 93 541 | 93 541 | |||||
2014-09-03 | 3 | Vandervelpen Nico | NERV | No securities are beneficially owned. | D | 0 | ||||||||
2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6 568 706 | ||||||||
2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6 568 706 | ||||||||
2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6 568 706 | ||||||||
2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 207 869 | 649 842 | |||||
2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 441 973 | 441 973 | |||||
2014-07-09 | 2014-06-30 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127 513 | 127 513 | |||||
2014-07-09 | 2014-07-01 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 6,0000 | 3 333 | 20 | 3 333 | ||||
2014-07-09 | 2014-06-30 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 6,00 | 51 967 | 51 967 | |||||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −61 922 | −372 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −114 077 | −684 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 333 333 | 2 000 | 5 285 638 | ||||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 1 287 500 | 7 725 | 4 952 305 | ||||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 61 922 | 372 | 3 664 805 | ||||
2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 114 077 | 684 | 3 602 883 | ||||
2014-07-09 | 2014-07-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 6,0000 | 10 000 | 60 | 10 000 | ||||
2014-07-09 | 2014-06-30 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93 541 | 93 541 | |||||
2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −61 923 | −372 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −114 078 | −684 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 737 500 | 4 425 | 3 883 212 | ||||
2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 61 923 | 372 | 3 145 712 | ||||
2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 114 078 | 684 | 3 083 789 | ||||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −61 922 | −372 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −114 077 | −684 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 333 333 | 2 000 | 5 285 638 | ||||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 1 287 500 | 7 725 | 4 952 305 | ||||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 61 922 | 372 | 3 664 805 | ||||
2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 114 077 | 684 | 3 602 883 | ||||
2014-07-09 | 2014-07-01 | 4 | Vivaldi Coelho Rogerio | NERV | Common Stock | D | 6,0000 | 41 667 | 250 | 41 667 | ||||
2014-07-09 | 2014-06-30 | 4 | Vivaldi Coelho Rogerio | NERV | Employee Stock Option (right to buy) | D | 6,00 | 498 621 | 498 621 | |||||
2014-07-09 | 2014-07-01 | 4 | Race Geoff | NERV | Common Stock | D | 6,0000 | 33 333 | 200 | 206 648 | ||||
2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 249 442 | 346 585 | |||||
2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 97 143 | 97 143 | |||||
2014-07-09 | 2014-07-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 6,0000 | 8 333 | 50 | 8 333 | ||||
2014-07-09 | 2014-06-30 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93 541 | 93 541 | |||||
2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −61 923 | −372 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −114 078 | −684 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 737 500 | 4 425 | 3 883 212 | ||||
2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 61 923 | 372 | 3 145 712 | ||||
2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 114 078 | 684 | 3 083 789 | ||||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −61 922 | −372 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | −114 077 | −684 | 0 | |||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 333 333 | 2 000 | 5 285 638 | ||||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 1 287 500 | 7 725 | 4 952 305 | ||||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 61 922 | 372 | 3 664 805 | ||||
2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 114 077 | 684 | 3 602 883 | ||||
2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346 630 | ||||||||
2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346 630 | ||||||||
2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1 853 208 | ||||||||
2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1 853 208 | ||||||||
2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5 939 422 | ||||||||
2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6 873 796 | ||||||||
2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6 873 796 |